Ticker Details
Codexis, Inc. Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels.
IPO Date:	April 22, 2010
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$150.84M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 2.80%
Avg Daily Range (30 D):	$0.04 | 2.51%
Avg Daily Range (90 D):	$0.06 | 2.89%

Institutional Daily Volume
Avg Daily Volume:	.34M
Avg Daily Volume (30 D):	.85M
Avg Daily Volume (90 D):	.8M

Trade Size
Avg Trade Size (Sh.):	113
Avg Trade Size (Sh.) (30 D):	224
Avg Trade Size (Sh.) (90 D):	180

Institutional Trades
Total Institutional Trades:	1,259
Avg Institutional Trade:	$1.46M
Avg Institutional Trade (30 D):	$1.1M
Avg Institutional Trade (90 D):	$.93M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.28M
Avg Closing Trade (30 D):	$.52M
Avg Closing Trade (90 D):	$.7M
Avg Closing Volume:	92.84K

News

Aug 28, 2025 @ 1:00 PM Codexis to Participate in Cantor Global Healthcare... Source: Georgia Erbez

May 22, 2025 @ 11:00 AM Codexis’ Landmark Presentations at TIDES US... Source: N/A

Apr 9, 2025 @ 9:00 PM Codexis Announces Byron Dorgan to Retire from Boar... Source: N/A

Feb 20, 2025 @ 3:00 PM Specialty Enzymes Market to Expand at 7.5% CAGR, R... Source: Sns Insider

Dec 4, 2024 @ 6:00 PM Global Artificial Sweeteners Market to Observe Gro... Source: Delveinsight

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$-.22
Diluted EPS		$-.22
Revenue		$8.6M
Gross Profit		$6.14M
Net Income / Loss		$-19.62M
Operating Income / Loss		$-18.95M
Cost of Revenue		$2.47M
Net Cash Flow
PE Ratio